Justyna Leja - Concepedia

Author

Justyna Leja

Uppsala University

Also Known As

J Leja, J. Leja, Justyna Leja

Publications

464

Citations

H-Index

Concepts

All Affiliations

Uppsala University Uppsala University Hospital Science for Life Laboratory

About

Justyna Leja is an author at Uppsala University specializing in medicine, pathology, and tumor microenvironment.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	200
2	Immunology	2	2	42
3	Pathology	2	2	190
4	Cell Biology	1	1	10
5	Cell Signaling	1	1	10

Justyna Leja

Publications

456

Citations

H-Index

Page 1

	Year	Citations
Novel markers for enterochromaffin cells and gastrointestinal neuroendocrine carcinomas Justyna Leja, Ahmed Essaghir, Magnus Essand, Modern Pathology Gastrointestinal OncologyPathologyNovel MarkersMedicineTumor Microenvironment	2008	158
Combined vascular endothelial growth factor-A and fibroblast growth factor 4 gene transfer improves wound healing in diabetic mice Agnieszka Jaźwa, Paulina Kucharzewska, Justyna Leja, Genetic Vaccines and Therapy	2010	61
Systemic treatment with CAR-engineered T cells against PSCA delays subcutaneous tumor growth and prolongs survival of mice Victoria Hillerdal, Mohanraj Ramachandran, Justyna Leja, BMC Cancer	2014	58
Double-Detargeted Oncolytic Adenovirus Shows Replication Arrest in Liver Cells and Retains Neuroendocrine Cell Killing Ability Justyna Leja, Berith Nilsson, Di Yu, PLoS ONE	2010	55
Adenovirus with Hexon Tat-Protein Transduction Domain Modification Exhibits Increased Therapeutic Effect in Experimental Neuroblastoma and Neuroendocrine Tumors Di Yu, Chuan Jin, Justyna Leja, Journal of Virology	2011	41
A Novel Chromogranin-A Promoter-Driven Oncolytic Adenovirus for Midgut Carcinoid Therapy Justyna Leja, Helena Dzojic, Elisabet Gustafson, Clinical Cancer Research	2007	41
Oncolytic adenovirus modified with somatostatin motifs for selective infection of neuroendocrine tumor cells Justyna Leja, Di Yu, Bo Nilsson, Gene Therapy ImmunologyPathologyVirologySomatostatin MotifsImmunotherapy	2011	32
Tat-PTD-Modified Oncolytic Adenovirus Driven by the SCG3 Promoter and ASH1 Enhancer for Neuroblastoma Therapy Chuan Jin, Di Yu, Matko Čančer, Human Gene Therapy Scg3 PromoterAsh1 EnhancerImmunologyNeuroblastoma TherapyTumor Biology	2013	10

Page 1